Great_老虎社区_美港股上老虎

Marcurzed
2021-06-24

Great

Biogen Stock Drops Premarket

Biogen shares dropped over 7% in premarket trading. The stock has soared since the FDA gave its sta

Biogen Stock Drops Premarket

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":126029283,"tweetId":"126029283","gmtCreate":1624538381042,"gmtModify":1634004721158,"author":{"id":4087628888775460,"idStr":"4087628888775460","authorId":4087628888775460,"authorIdStr":"4087628888775460","name":"Marcurzed","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":1,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Great</p></body></html>","htmlText":"<html><head></head><body><p>Great</p></body></html>","text":"Great","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/126029283","repostId":1154733193,"repostType":4,"repost":{"id":"1154733193","kind":"news","pubTimestamp":1624536552,"share":"https://www.laohu8.com/m/news/1154733193?lang=&edition=full","pubTime":"2021-06-24 20:09","market":"us","language":"en","title":"Biogen Stock Drops Premarket","url":"https://stock-news.laohu8.com/highlight/detail?id=1154733193","media":"The Wall Street Journal","summary":"Biogen shares dropped over 7% in premarket trading.\n\nThe stock has soared since the FDA gave its sta","content":"<p>Biogen shares dropped over 7% in premarket trading.</p>\n<p><img src=\"https://static.tigerbbs.com/03125372f62e0f168465fa41a7405a57\" tg-width=\"658\" tg-height=\"440\"></p>\n<p>The stock has soared since the FDA gave its stamp of approval for an Alzheimer's drug from Biogen earlier this month. As of Wednesday close, the stock was up over 50% this year, compared with the S&amp;P 500's roughly 13% advance.</p>\n<p>The drug would be the first new treatment for the disease in decades. But the FDA approval has been mired in controversy, with the agency's own statisticians saying there was insufficient evidence to support approval.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Biogen Stock Drops Premarket</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBiogen Stock Drops Premarket\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-24 20:09 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/dxN6UHk54SMgjBK70YIp><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Biogen shares dropped over 7% in premarket trading.\n\nThe stock has soared since the FDA gave its stamp of approval for an Alzheimer's drug from Biogen earlier this month. As of Wednesday close, the ...</p>\n\n<a href=\"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/dxN6UHk54SMgjBK70YIp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIIB":"渤健公司"},"source_url":"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/dxN6UHk54SMgjBK70YIp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1154733193","content_text":"Biogen shares dropped over 7% in premarket trading.\n\nThe stock has soared since the FDA gave its stamp of approval for an Alzheimer's drug from Biogen earlier this month. As of Wednesday close, the stock was up over 50% this year, compared with the S&P 500's roughly 13% advance.\nThe drug would be the first new treatment for the disease in decades. But the FDA approval has been mired in controversy, with the agency's own statisticians saying there was insufficient evidence to support approval.","news_type":1},"isVote":1,"tweetType":1,"viewCount":508,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":5,"xxTargetLangEnum":"ORIG"},"commentList":[],"hasMoreComment":false,"orderType":2}